Efficient Hepatic Delivery and Expression from a Recombinant Adeno-associated Virus 8 Pseudotyped α1-Antitrypsin Vector
Open Access
- 30 November 2005
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 12 (5) , 867-875
- https://doi.org/10.1016/j.ymthe.2005.05.016
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Recent developments and current status of gene therapy using viral vectors in the United Kingdom: Table 1BMJ, 2004
- Rapid Uncoating of Vector Genomes Is the Key toEfficient Liver Transduction with Pseudotyped Adeno-Associated VirusVectorsJournal of Virology, 2004
- Characterization of the Transcription Profile of Adeno-Associated Virus Type 5 Reveals a Number of Unique Features Compared to Previously Characterized Adeno-Associated VirusesJournal of Virology, 2002
- Intramuscular Administration of Recombinant Adeno-Associated Virus 2 α-1 Antitrypsin (rAAV-SERPINA1) Vectors in a Nonhuman Primate Model: Safety and Immunologic AspectsMolecular Therapy, 2002
- Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectorsGene Therapy, 2001
- Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectorsGene Therapy, 2001
- High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and CapGene Therapy, 1999
- A novel SV40-based vector successfully transduces and expresses an alpha 1-antitrypsin ribozyme in a human hepatoma-derived cell lineGene Therapy, 1999
- Ex Vivo and In Vivo Gene Transfer to The Skin Using Replication-Deficient Recombinant Adenovirus VectorsJournal of Investigative Dermatology, 1994
- Replacement Therapy for Alpha1-Antitrypsin Deficiency Associated with EmphysemaNew England Journal of Medicine, 1987